Alternative investment funds managed by European regulated asset managers
The data shown is taken from a database provided by european regulators. Date of update: 2025-04-10
Fund type available: AIF, ELTIF, EuSEF and EuVECA.
Click on the Fund’s LEI for more information or Use our search module for additional data.
| Fund Manager Name | Fund Name | Fund Type | Fund Manager State | Fund Manager LEI | Fund LEI |
|---|---|---|---|---|---|
| 1741 Fund Management AG | CREA Vision Funds Investmentgesellschaft AGmvK - Special Concentrated Equity Fund | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 549300E6ZF6RNBKREO47 |
| CAIAC Fund Management AG | 21.funds SICAV - IFFF - International Football Finance | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500XFGYPGG6G5DM88 |
| CAIAC Fund Management AG | Atlas Investment Funds - Equity Long Short Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500EV7ZQ8XWGSFX94 |
| CAIAC Fund Management AG | Future X investment community Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500K2RC8OHTFDHM33 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP Global Life Sciences Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900O2C4X7RGZBXV21 |
| CAIAC Fund Management AG | Progressive Opportunity Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 52990053FNMNE8B4RJ89 |
| Accuro Fund Solutions AG | Premium Strategy 7 Plus Fund | AIF | LIECHTENSTEIN | 529900UJ5383SU2X7B49 | 529900DAEIN253GI2788 |
| Accuro Fund Solutions AG | PROs Global Opportunities Fund | AIF | LIECHTENSTEIN | 529900UJ5383SU2X7B49 | 5299004VU5AV1USQE675 |
| Accuro Fund Solutions AG | Romania Strategy Fund | AIF | LIECHTENSTEIN | 529900UJ5383SU2X7B49 | 529900SYZRQWRTWV2A40 |
| CAIAC Fund Management AG | SafePort Precious Metals Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 529900GMQGI7XA3VGH47 |
| CAIAC Fund Management AG | Progressive Opportunity Fund II | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 5299003IN7L42B0LG733 |
| CAIAC Fund Management AG | Progressive Opportunity Fund Signum | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500URPZ8TXQ10LP94 |
| CAIAC Fund Management AG | Qualitium Opportunity Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 529900Y60AT8QP1V2E88 |
| CAIAC Fund Management AG | R2 Umbrella Fund - ELBE Alternative Investment Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500HZVJLO5WZR4X51 |
| CAIAC Fund Management AG | R2 Umbrella Fund - Fairness Alternative Investment Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500DNMMD2QFIK6640 |
| Ahead Wealth Solutions AG | Allegretto Invest | AIF | LIECHTENSTEIN | 5299008WBM29C45SRF98 | 529900WYYLDPM9AFWO69 |
| Ahead Wealth Solutions AG | AIPM Investmentgesellschaft AGmvK - AIPM Strategy Fund | AIF | LIECHTENSTEIN | 5299008WBM29C45SRF98 | 5299008BCWRFPKMH4466 |
| 1741 Fund Management AG | ONG Invest SICAV - ONG Invest Securities Fund | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900GVSWOXCZHVP111 |
| 1741 Fund Management AG | Gate House Investment SICAV - Gate House Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900CE8O9UOMU87548 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP Asia Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 5493002HL4DGKJZF7I46 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP Asia Fund II | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 549300C4WYY6HQM38N77 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP Debt Fund USD | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 549300M5SKIDD1H8J610 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP Income Opportunities Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900O3S5VOYGNJ3V48 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP India Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 549300PY4BLE4AEQMY42 |
| 1741 Fund Management AG | MAP lnvestmentgesellschaft AGmvK - MAP Life Sciences Europe Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 54930086I9RP2E5ED835 |
Warning: The AIF funds listed here are reserved for professional or institutional investors. These products are not authorised for sale to the general public. Subscription by private individuals is prohibited, unless otherwise provided for by the regulations.